Suppr超能文献

肠道微生物代谢产物吲哚-3-乙酸通过黏蛋白硫酸盐化维持肠道上皮细胞稳态。

Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation.

机构信息

Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, National Key Clinical Specialty, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China.

Department of Immunology, Nankai University School of Medicine, Nankai University, Tianjin, China.

出版信息

Gut Microbes. 2024 Jan-Dec;16(1):2377576. doi: 10.1080/19490976.2024.2377576. Epub 2024 Jul 27.

Abstract

The global incidence and prevalence of inflammatory bowel disease (IBD) are gradually increasing. A high-fat diet (HFD) is known to disrupt intestinal homeostasis and aggravate IBD, yet the underlying mechanisms remain largely undefined. Here, a positive correlation between dietary fat intake and disease severity in both IBD patients and murine colitis models is observed. A HFD induces a significant decrease in indole-3-acetic acid (IAA) and leads to intestinal barrier damage. Furthermore, IAA supplementation enhances intestinal mucin sulfation and effectively alleviates colitis. Mechanistically, IAA upregulates key molecules involved in mucin sulfation, including 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (Papss2) and solute carrier family 35 member B3 (Slc35b3), the synthesis enzyme and the transferase of 3'-phosphoadenosine-5'-phosphosulfate (PAPS), via the aryl hydrocarbon receptor (AHR). More importantly, AHR can directly bind to the transcription start site of Papss2. Oral administration of , which can produce IAA, contributes to protecting against colitis and promoting mucin sulfation, while the modified strain lacking the gene () and the ability to produce IAA fail to exhibit such effects. Overall, IAA enhances intestinal mucin sulfation through the AHR-Papss2-Slc35b3 pathway, contributing to the protection of intestinal homfeostasis.

摘要

炎症性肠病(IBD)的全球发病率和患病率正在逐渐上升。已知高脂肪饮食(HFD)会破坏肠道内稳态并加重 IBD,但潜在机制在很大程度上仍未得到明确。在这里,观察到饮食脂肪摄入与 IBD 患者和鼠结肠炎模型中的疾病严重程度之间存在正相关关系。HFD 可显著降低吲哚-3-乙酸(IAA)并导致肠道屏障损伤。此外,IAA 补充可增强肠道粘蛋白硫酸化,并有效缓解结肠炎。在机制上,IAA 通过芳基烃受体(AHR)上调粘蛋白硫酸化涉及的关键分子,包括 3'-磷酸腺苷 5'-磷酸硫酸合酶 2(Papss2)和溶质载体家族 35 成员 B3(Slc35b3),即 3'-磷酸腺苷-5'-磷酸硫酸(PAPS)的合成酶和转移酶。更重要的是,AHR 可以直接结合到 Papss2 的转录起始位点。口服可以产生 IAA 的 ,有助于预防结肠炎和促进粘蛋白硫酸化,而缺乏 基因()且无法产生 IAA 的改良 菌株()则无法表现出这种作用。总体而言,IAA 通过 AHR-Papss2-Slc35b3 途径增强肠道粘蛋白硫酸化,有助于保护肠道内稳态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/349c/11285290/b3a7c24cc949/KGMI_A_2377576_UF0001_OC.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验